Riskpilot← Back to searchSign inGet full accessDYRETANNKLINIKKEN AS
ASActiveOrg 920544339Andebuveien 3, 3170 SemVeterinary activities · NACE 7500Est. 20188 employees
Revenue 2024
NOK 11M
+6% vs 2023
EBITDA margin
24.4%
+17% vs 2023
Equity ratio
49.0%
Financial strength
Net profit 2024
NOK 1,7M
+34% vs 2023
| Revenue | NOK 11M | +6% |
| EBITDA | NOK 2,7M | +17% |
| Net profit | NOK 1,7M | +34% |
| Total assets | NOK 4,6M | +8% |
| Equity | NOK 2,3M | +124% |
| Employees | 8 | — |
Legal name
DYRETANNKLINIKKEN AS
Org number
920544339
Legal form
Aksjeselskap
NACE code
7500 · Veterinary activities
Founded
6. mars 2018
Share capital
NOK 30 000
Employees
8 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Veterinærvirksomhet og annen virksomhet som står i forbindelse med dette.
Address
Andebuveien 3, 3170 Sem
Phone
+4797573000
Email
post@dyretannklinikken.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 6 224 | 7 861 | 9 095 | 10 349 | 11 013 |
| Staff expenses | −2 498 | −2 875 | −3 798 | −4 774 | −5 282 |
| EBITDA | 1 484 | 2 330 | 2 253 | 2 286 | 2 685 |
| Depreciation & amort. | −699 | −677 | −643 | −595 | −497 |
| EBIT | 786 | 1 653 | 1 610 | 1 691 | 2 188 |
| Net financials | −190 | −104 | −46 | −2 | 19 |
| Profit before tax | 596 | 1 550 | 1 563 | 1 689 | 2 207 |
| Tax | 133 | 389 | 371 | 386 | 457 |
| Net profit | 463 | 1 160 | 1 193 | 1 303 | 1 750 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 212 | 4 486 | 4 050 | 4 262 | 4 606 |
| Equity | 25 | 1 110 | 1 303 | 1 006 | 2 256 |
| Long-term debt | 3 436 | 1 834 | 151 | 0 | 0 |
| Short-term debt | 752 | 1 541 | 2 596 | 3 256 | 2 350 |
| Total debt | 4 188 | 3 375 | 2 747 | 3 256 | 2 350 |
EBITDA margin
24.4%
This company
15.8%
Market median
+54% vs market
20202024
Equity ratio
49.0%
This company
38.2%
Market median
+28% vs market
20202024
Return on equity
77.6%
This company
18.4%
Market median
+322% vs market
20202024
Net profit margin
15.9%
This company
8.1%
Market median
+96% vs market
20202024
Asset turnover
2.39×
This company
1.12×
Market median
+113% vs market
20202024
Debt / equity
1.04×
This company
0.62×
Market median
-68% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SH Chief Executive Officer | Chief Executive Officer | 2018 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2025 | |
| Former (1) | ||
| Board of Directors | 2018 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Bull & Storli Consult As
DYRETANNKLINIKKEN AS Board members of DYRETANNKLINIKKEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sigbjørn Hesthammer Storli | Chief Executive Officer | 0 companies |
| Eirik Nilssen | Chairman | 0 companies |
| Ingeling Bull | Board of Directors | 0 companies |